Oryzon to present at upcoming international conferences

MADRID, SPAIN and CAMBRIDGE MA.

• HC Wainwright Global Life Sciences Conference - 2018, Monaco

• AACR Annual Meeting 2018, Chicago, Illinois, United States

• 13th edition of the European Smallcap Event, Paris, France

Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that Executive Directors of the company will present at several international reputed conferences.

Click here to see the full Press Release